| Market Cap | 66.42M | P/E | - | EPS this Y | -42.10% | Ern Qtrly Grth | - |
| Income | -4.54M | Forward P/E | -7.05 | EPS next Y | 22.20% | 50D Avg Chg | 38.00% |
| Sales | 18.8M | PEG | -0.40 | EPS past 5Y | - | 200D Avg Chg | 42.00% |
| Dividend | N/A | Price/Book | 2.08 | EPS next 5Y | 15.00% | 52W High Chg | -38.00% |
| Recommedations | 1.70 | Quick Ratio | 3.93 | Shares Outstanding | 26.35M | 52W Low Chg | 149.00% |
| Insider Own | 5.63% | ROA | -7.67% | Shares Float | 24.82M | Beta | 1.51 |
| Inst Own | 25.23% | ROE | -14.86% | Shares Shorted/Prior | 196.76K/230.81K | Price | 2.61 |
| Gross Margin | 87.08% | Profit Margin | -12.13% | Avg. Volume | 1,421,008 | Target Price | 4.83 |
| Oper. Margin | -38.74% | Earnings Date | Nov 11 | Volume | 365,421 | Change | -2.97% |
iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.
| Lake Street | Buy | Jul 19, 23 |
| JMP Securities | Outperform | Apr 13, 23 |
| Oppenheimer | Outperform | Apr 4, 23 |
| BTIG | Buy | Mar 29, 23 |
| Lake Street | Buy | Mar 29, 23 |
| JMP Securities | Market Outperform | Sep 1, 22 |
| Lake Street | Buy | Aug 11, 22 |
| BTIG | Buy | Jun 24, 22 |
| Guggenheim | Neutral | Jan 18, 22 |
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Irish Timothy Norris | Director Director | Mar 03 | Buy | 4.63 | 5,500 | 25,465 | 5,500 | 03/03/22 |
| SASSINE ANDY | Director Director | Jan 06 | Sell | 6.14 | 20,000 | 122,800 | 1,218,382 | 01/11/22 |
| Go Jonathan | Chief Technology Off.. Chief Technology Officer | Nov 08 | Option | 3.15 | 30,000 | 94,500 | 151,435 | 11/10/21 |
| Go Jonathan | Chief Technology Off.. Chief Technology Officer | Nov 08 | Sell | 10.86 | 8,750 | 95,025 | 142,685 | 11/10/21 |
| SASSINE ANDY | Director Director | Sep 15 | Sell | 10.89 | 20,000 | 217,800 | 1,298,382 | 09/15/21 |
| Stevens Stacey M | President President | Jun 23 | Option | 5.53 | 8,568 | 47,381 | 150,954 | 06/23/21 |
| Stevens Stacey M | President President | Jun 23 | Sell | 18.1 | 17,735 | 321,004 | 142,621 | 06/23/21 |
| Areglado R. Scott | Chief Financial Offi.. Chief Financial Officer | Dec 10 | Option | 6 | 15,000 | 90,000 | 51,911 | 12/10/20 |
| Areglado R. Scott | Chief Financial Offi.. Chief Financial Officer | Dec 10 | Sell | 12 | 15,000 | 180,000 | 36,911 | 12/10/20 |
| Stevens Stacey M | President President | Dec 07 | Option | 6.68 | 19,765 | 132,030 | 190,453 | 12/07/20 |
| Stevens Stacey M | President President | Dec 07 | Sell | 11.18 | 19,765 | 220,973 | 171,788 | 12/07/20 |